Schrum Private Wealth Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 6.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,738 shares of the medical equipment provider’s stock after purchasing an additional 169 shares during the quarter. Schrum Private Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,345,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in ISRG. Mirador Capital Partners LP increased its position in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. Advisors Asset Management Inc. increased its holdings in Intuitive Surgical by 18.1% during the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after buying an additional 1,129 shares during the last quarter. Consolidated Planning Corp raised its position in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after acquiring an additional 1,198 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares during the last quarter. Finally, Brookstone Capital Management grew its position in shares of Intuitive Surgical by 22.4% during the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after acquiring an additional 2,289 shares during the period. 83.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
ISRG has been the topic of a number of research reports. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Barclays upped their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. BTIG Research set a $535.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Citigroup increased their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.
Intuitive Surgical Trading Down 0.1 %
Shares of ISRG traded down $0.54 during mid-day trading on Wednesday, reaching $536.53. 195,670 shares of the stock traded hands, compared to its average volume of 1,453,816. Intuitive Surgical, Inc. has a 1 year low of $287.98 and a 1 year high of $542.59. The company has a market cap of $191.10 billion, a price-to-earnings ratio of 86.35, a price-to-earnings-growth ratio of 5.27 and a beta of 1.39. The firm has a fifty day moving average price of $495.85 and a 200 day moving average price of $455.08.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.
Insider Buying and Selling
In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 91,178 shares of company stock worth $45,897,071. Insiders own 0.80% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- 10 Best Airline Stocks to Buy
- Rocket Lab is the Right Stock for the Right Time
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Transportation Stocks Investing
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.